Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-12-04, Stock:LLY, The news for the past five days is as follows:
2018-11-27: NEWS1: Zafgen (ZFGN) Plunges as FDA Puts Hold on Diabetes Drug Trial.NEWS2: Lilly to Announce 2019 Financial Guidance, Highlight Late-Stage Pipeline Opportunities and Discuss Commercial Performance at Upcoming Investment Community Meeting.NEWS3: American College of Cardiology recommends empagliflozin as preferred SGLT2 inhibitor for adults with type 2 diabetes and established cardiovascular disease in new Expert Consensus Decision Pathway.
2018-11-28: NEWS1: Is Eli Lilly and (LLY) Stock Outpacing Its Medical Peers This Year?.NEWS2: Is Eli Lilly and (LLY) Stock Outpacing Its Medical Peers This Year?.NEWS3: Is Eli Lilly and (LLY) Stock Outpacing Its Medical Peers This Year?.NEWS4: Zafgen (ZFGN) Plunges as FDA Puts Hold on Diabetes Drug Trial.NEWS5: Zafgen (ZFGN) Plunges as FDA Puts Hold on Diabetes Drug Trial.
2018-11-29: NEWS1: Merck (MRK) Receives Approval for 2 HIV Medicines in EU.NEWS2: Merck (MRK) Receives Approval for 2 HIV Medicines in EU.NEWS3: Merck (MRK) Receives Approval for 2 HIV Medicines in EU.NEWS4: iShares Edge MSCI Min Vol Global ETF Experiences Big Inflow.NEWS5: iShares Edge MSCI Min Vol Global ETF Experiences Big Inflow.NEWS6: Alkermes touts &apos;positive&apos; schizophrenia drug data, but investors not impressed.NEWS7: Alkermes shares dip despite &apos;positive&apos; trial results from schizophrenia drug.NEWS8: 4 Big Pharma Stocks to Add to Your Portfolio in December.NEWS9: 4 Big Pharma Stocks to Add to Your Portfolio in December.NEWS10: 4 Big Pharma Stocks to Add to Your Portfolio in December.NEWS11: Lilly to Present Clinical Data for Verzenio® (abemaciclib) and Real-World Evidence across HR+, HER2- Metastatic Breast Cancer at 2018 SABCS.
2018-11-30: NEWS1: Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know.NEWS2: Insiders Roundup: Walmart, Eli Lilly.NEWS3: Noteworthy Friday Option Activity: LLY, GE, ADM.NEWS4: Noteworthy Friday Option Activity: LLY, GE, ADM.NEWS5: 3 Tips for Trading the Fed's More Dovish Stance.NEWS6: Lilly (LLY) Hits Fresh High: Is There Still Room to Run?.
2018-12-03: NEWS1: NCCN Oncology Research Program Awarded $2 Million from Lilly to Study Mechanisms of Resistance to CDK4 & 6 Inhibitors in Breast Cancer Treatment.NEWS2: Investor Expectations to Drive Momentum within Virtu Financial, Fate Therapeutics, Tandem Diabetes Care, Eli Lilly, Griffon, and Coherus BioSciences — Discovering Underlying Factors of Influence.

Answer: Decrease